Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice
Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice
复制标题
DOI:
10.1016/s0304-3835(02)00200-8
复制
发表时间:
2002-10-08
期刊:
影响因子:
9.7
通讯作者:
Newbold, RR
中科院分区:
文献类型:
--
作者:
Doerge, DR;Twaddle, NC;Newbold, RR
Genistein, the principal soy isoflavone, was Previously shown to induce uterine adenocarcinomas by 18 months of age in female CD-1 mice following administration by subcutaneous injections on postnatal days 1-5. A serum pharmacokinetic analysis of genistein in male and female mice treated identically showed that: maximal concentrations of total (conjugated + aglycone) genistein in females (6.8 +/- 1.4 muM) and males (3.8 +/- 1.1 muM, mean +/- SD) were comparable to those previously reported from dietary exposures in adult rats or in human infants consuming soy formulas; the average fraction present as active aglycone (31%) was similar to those in fetal and neonatal rats from placental and lactational exposures; and elimination half-times were longer than those in rats (three- to seven-fold) and adult humans (two- to three-fold). These results are consistent with a diminished capacity for enzymatic conjugation of genistein, based on the ontogeny, as an important determinant of estrogenicity in neonatal mice. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.